Zdrowie i gospodarka · 06/02/2014

FDA Requests Public Comment on Proposed Collection of Pharmacogenomic Data

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to pharmacogenomic data submissions during the drug development process, as required by the Paperwork Reduction Act of 1995.